[go: up one dir, main page]

NO964915D0 - Transdermal avlevering av antiepileptiske legemidler - Google Patents

Transdermal avlevering av antiepileptiske legemidler

Info

Publication number
NO964915D0
NO964915D0 NO964915A NO964915A NO964915D0 NO 964915 D0 NO964915 D0 NO 964915D0 NO 964915 A NO964915 A NO 964915A NO 964915 A NO964915 A NO 964915A NO 964915 D0 NO964915 D0 NO 964915D0
Authority
NO
Norway
Prior art keywords
transdermal delivery
antiepileptic drugs
antiepileptic
drugs
transdermal
Prior art date
Application number
NO964915A
Other languages
English (en)
Other versions
NO964915L (no
Inventor
Helle Weibel
Peter Bonne Eriksen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8095138&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO964915(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO964915L publication Critical patent/NO964915L/no
Publication of NO964915D0 publication Critical patent/NO964915D0/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10Peptides having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245Escherichia (G)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO964915A 1994-05-20 1996-11-19 Transdermal avlevering av antiepileptiske legemidler NO964915D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK57794 1994-05-20
PCT/DK1995/000194 WO1995031976A1 (en) 1994-05-20 1995-05-17 Transdermal delivery of anti-epileptic drugs

Publications (2)

Publication Number Publication Date
NO964915L NO964915L (no) 1996-11-19
NO964915D0 true NO964915D0 (no) 1996-11-19

Family

ID=8095138

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964915A NO964915D0 (no) 1994-05-20 1996-11-19 Transdermal avlevering av antiepileptiske legemidler

Country Status (20)

Country Link
US (1) US5750140A (no)
EP (1) EP0760656A1 (no)
JP (1) JPH10500415A (no)
KR (1) KR970703146A (no)
CN (1) CN1148806A (no)
AU (1) AU698131B2 (no)
BR (1) BR9507736A (no)
CA (1) CA2190837C (no)
CZ (1) CZ338196A3 (no)
FI (1) FI964619A0 (no)
HU (1) HUT75864A (no)
IL (1) IL113793A (no)
NO (1) NO964915D0 (no)
NZ (1) NZ287012A (no)
PE (1) PE2596A1 (no)
RU (1) RU2152784C1 (no)
SK (1) SK281076B6 (no)
TW (1) TW372875B (no)
WO (1) WO1995031976A1 (no)
ZA (1) ZA954118B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA52661C2 (uk) * 1996-06-14 2003-01-15 Ново Нордіск А/С Безводна кристалічна форма гідрохлориду r(-)-n-(4,4-ди(3-метилтієн-2-іл)бут-3-еніл) ніпекотинової кислоти
US5914333A (en) * 1996-07-31 1999-06-22 Novo Nordisk A/S Treatment of psychotic disorders
US6537537B2 (en) 1997-06-12 2003-03-25 The Procter & Gamble Company Water-in-silicone emulsion cosmetic compositions
GB9712269D0 (en) * 1997-06-12 1997-08-13 Procter & Gamble Cosmetic composition
GB9712271D0 (en) * 1997-06-12 1997-08-13 Procter & Gamble Cosmetic composition
US6316010B2 (en) 1997-06-12 2001-11-13 The Procter & Gamble Company Cosmetic compositions
GB9712272D0 (en) * 1997-06-12 1997-08-13 Procter & Gamble Cosmetic composition
DK0991409T3 (da) * 1997-08-01 2002-03-25 Elan Corp Plc Farmaceutiske tiagabinindeholdende præparater med reguleret frigivelse
IE970588A1 (en) 1997-08-01 2000-08-23 Elan Corp Plc Controlled release pharmaceutical compositions containing tiagabine
FR2771292B1 (fr) * 1997-11-21 2000-02-18 Ethypharm Lab Prod Ethiques Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques
CA2479672A1 (en) * 2002-03-18 2003-10-02 Roger K. Cady Preemptive prophylaxis of migraine
MX2020001525A (es) 2017-08-24 2020-03-20 Novo Nordisk As Composiciones de peptido similar al glucagon tipo 1 (glp-1) y sus usos.
IL294521A (en) 2020-02-18 2022-09-01 Novo Nordisk As glp-1 compounds and their uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2105990B (en) * 1981-08-27 1985-06-19 Nitto Electric Ind Co Adhesive skin patches
DK288385D0 (da) * 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
SE8904296D0 (sv) * 1989-12-21 1989-12-21 Pharmacia Ab Transdermal system
DK58291D0 (da) * 1991-04-02 1991-04-02 Novo Nordisk As Krystalinsk stof og dets fremstilling

Also Published As

Publication number Publication date
HUT75864A (en) 1997-05-28
CA2190837C (en) 2005-08-02
AU698131B2 (en) 1998-10-22
FI964619L (fi) 1996-11-19
CZ338196A3 (en) 1997-06-11
KR970703146A (ko) 1997-07-03
IL113793A0 (en) 1995-08-31
JPH10500415A (ja) 1998-01-13
EP0760656A1 (en) 1997-03-12
NO964915L (no) 1996-11-19
TW372875B (en) 1999-11-01
US5750140A (en) 1998-05-12
ZA954118B (en) 1996-11-19
RU2152784C1 (ru) 2000-07-20
FI964619A7 (fi) 1996-11-19
NZ287012A (en) 1998-09-24
CN1148806A (zh) 1997-04-30
CA2190837A1 (en) 1995-11-30
HU9603206D0 (en) 1997-01-28
SK281076B6 (sk) 2000-11-07
BR9507736A (pt) 1997-08-19
WO1995031976A1 (en) 1995-11-30
FI964619A0 (fi) 1996-11-19
SK148296A3 (en) 1997-06-04
PE2596A1 (es) 1996-02-12
IL113793A (en) 1999-12-31
AU2559995A (en) 1995-12-18

Similar Documents

Publication Publication Date Title
DE69938299D1 (de) Lokale abgabe von arzneimitteln
NO963990D0 (no) To-komponentanordning for tilförsel av medikamenter
FI972292A0 (fi) Administrering av diabetes
MA26549A1 (fr) Medicaments
FI973243A0 (fi) Uusi farmaseuttinen yhdistelmä
EE9700241A (et) Farmatseutiline kompositsioon transdermaalseks manustamiseks
FI971279A0 (fi) Lääkkeitä
DK0754061T3 (da) Ny oral farmaceutisk doseringsform
DE69634053D1 (de) Oral anzuwendende Arzneizusammensetzung enthaltend 2-Methyl-thienobenzodiazepin
EE9800025A (et) Transkorneaalne süsteem ravimite manustamiseks
KR950703383A (ko) 초음파 경피약제전달 시스템(ultrasonic transdermal drug delivery system)
FR2767121B1 (fr) Distributeur de medicaments
NO962231L (no) Prolegemidler av paclitaxelderivater
NO964915D0 (no) Transdermal avlevering av antiepileptiske legemidler
EP0850057A4 (en) Pharmaceutical compounds
FI960887A7 (fi) Antimigreenilääkkeen iontoforeettinen kuljetus
FI950389A0 (fi) Ny medicinsk anvaendning av hemiprodukter
FI970053A7 (fi) Transdermaalinen lääkeaineen antosysteemi
SE9400861D0 (sv) Halvfast beredningsform för läkemedel
DE69634569D1 (de) Medikamentenabgabevorrichtung
BR9612652A (pt) Forma de administração farmacêutica
FI960435A0 (fi) Lääkkeiden transdermaalisen antotapaan tarkoitettuLääkkeiden transdermaalisen antotapaan tarkoitettu koostumus koostumus
UA25519A (uk) Спосіб іhтракаротидhого введеhhя лікарських препаратів
SE9401674L (sv) Läkemedel
NO944330D0 (no) Legemiddel

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application